• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本成年人动脉粥样硬化性心血管疾病风险预测模型的建立与验证:日上山研究。

Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study.

机构信息

Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University.

Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University.

出版信息

J Atheroscler Thromb. 2022 Mar 1;29(3):345-361. doi: 10.5551/jat.61960. Epub 2021 Jan 22.

DOI:10.5551/jat.61960
PMID:33487620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8894117/
Abstract

AIM

To develop and validate a new risk prediction model for predicting the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) in Japanese adults.

METHODS

A total of 2,454 participants aged 40-84 years without a history of cardiovascular disease (CVD) were prospectively followed up for 24 years. An incident ASCVD event was defined as the first occurrence of coronary heart disease or atherothrombotic brain infarction. A Cox proportional hazards regression model was used to construct the prediction model. In addition, a simplified scoring system was translated from the developed prediction model. The model performance was evaluated using Harrell's C statistics, a calibration plot with the Greenwood-Nam-D'Agostino test, and a bootstrap validation procedure.

RESULTS

During a median of a 24-year follow-up, 270 participants experienced the first ASCVD event. The predictors of the ASCVD events in the multivariable Cox model included age, sex, systolic blood pressure, diabetes, serum high-density lipoprotein cholesterol, serum low-density lipoprotein cholesterol, proteinuria, smoking habits, and regular exercise. The developed models exhibited good discrimination with negligible evidence of overfitting (Harrell's C statistics: 0.786 for the multivariable model and 0.789 for the simplified score) and good calibrations (the Greenwood-Nam-D'Agostino test: P=0.29 for the multivariable model, 0.52 for the simplified score).

CONCLUSION

We constructed a risk prediction model for the development of ASCVD in Japanese adults. This prediction model exhibits great potential as a tool for predicting the risk of ASCVD in clinical practice by enabling the identification of specific risk factors for ASCVD in individual patients.

摘要

目的

开发和验证一种新的风险预测模型,以预测日本成年人发生动脉粥样硬化性心血管疾病(ASCVD)的 10 年风险。

方法

共前瞻性随访了 2454 名年龄在 40-84 岁、无心血管疾病(CVD)病史的参与者,随访时间为 24 年。ASCVD 事件的定义为首次发生冠心病或动脉粥样血栓性脑梗死。采用 Cox 比例风险回归模型构建预测模型。此外,还从开发的预测模型中翻译了一个简化的评分系统。采用 Harrell 的 C 统计量、Greenwood-Nam-D'Agostino 检验的校准图和 bootstrap 验证程序评估模型性能。

结果

在中位数为 24 年的随访期间,270 名参与者发生了首次 ASCVD 事件。多变量 Cox 模型中 ASCVD 事件的预测因素包括年龄、性别、收缩压、糖尿病、血清高密度脂蛋白胆固醇、血清低密度脂蛋白胆固醇、蛋白尿、吸烟习惯和规律运动。开发的模型具有良好的区分度,几乎没有过度拟合的证据(Harrell 的 C 统计量:多变量模型为 0.786,简化评分模型为 0.789),且校准良好(Greenwood-Nam-D'Agostino 检验:多变量模型为 0.29,简化评分模型为 0.52)。

结论

我们构建了一个日本成年人 ASCVD 发病风险的预测模型。该预测模型通过识别个体患者 ASCVD 的特定风险因素,有望成为临床实践中预测 ASCVD 风险的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/5bef4471ec7b/29_61960_7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/95419c7993d6/29_61960_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/401aecc1694d/29_61960_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/219273045b60/29_61960_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/dd1c33d40cec/29_61960_4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/532565b17e62/29_61960_5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/73aa445b9980/29_61960_6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/5bef4471ec7b/29_61960_7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/95419c7993d6/29_61960_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/401aecc1694d/29_61960_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/219273045b60/29_61960_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/dd1c33d40cec/29_61960_4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/532565b17e62/29_61960_5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/73aa445b9980/29_61960_6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d9/8894117/5bef4471ec7b/29_61960_7.jpg

相似文献

1
Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study.日本成年人动脉粥样硬化性心血管疾病风险预测模型的建立与验证:日上山研究。
J Atheroscler Thromb. 2022 Mar 1;29(3):345-361. doi: 10.5551/jat.61960. Epub 2021 Jan 22.
2
Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease.他汀类药物治疗的已知心血管疾病患者的五年残余动脉粥样硬化性心血管疾病风险预测模型。
Am J Cardiol. 2020 Dec 15;137:7-11. doi: 10.1016/j.amjcard.2020.09.043. Epub 2020 Sep 28.
3
Development and validation of modified risk prediction models for cardiovascular disease and its subtypes: The Hisayama Study.改良心血管疾病及其亚型风险预测模型的建立与验证:日山研究。
Atherosclerosis. 2018 Dec;279:38-44. doi: 10.1016/j.atherosclerosis.2018.10.014. Epub 2018 Oct 17.
4
Development and validation of a novel 10-year cardiovascular risk prediction nomogram for the United Arab Emirates national population.开发和验证一种适用于阿联酋国民的新型 10 年心血管风险预测列线图。
BMJ Open. 2022 Dec 29;12(12):e064502. doi: 10.1136/bmjopen-2022-064502.
5
Application of a Lifestyle-Based Tool to Estimate Premature Cardiovascular Disease Events in Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.应用基于生活方式的工具评估年轻成年人过早发生心血管疾病事件:年轻成年人冠状动脉风险发展(CARDIA)研究。
JAMA Intern Med. 2017 Sep 1;177(9):1354-1360. doi: 10.1001/jamainternmed.2017.2922.
6
Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification.有无种族分层情况下动脉粥样硬化性心血管疾病的风险预测
JAMA Cardiol. 2024 Jan 1;9(1):55-62. doi: 10.1001/jamacardio.2023.4520.
7
Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease.开发和验证一种模型,以预测 2 型糖尿病和已确诊的动脉粥样硬化性心血管疾病患者的心血管死亡、非致死性心肌梗死或非致死性卒中。
Cardiovasc Diabetol. 2022 Aug 27;21(1):166. doi: 10.1186/s12933-022-01603-8.
8
Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.宇航员心血管健康和风险修正(Astro-CHARM)冠状动脉钙动脉粥样硬化性心血管疾病风险计算器。
Circulation. 2018 Oct 23;138(17):1819-1827. doi: 10.1161/CIRCULATIONAHA.118.033505.
9
Development of new scores for atherosclerotic cardiovascular disease using specific medical examination items: the Suita Study.利用特定体检项目开发动脉粥样硬化性心血管疾病新评分:Suita 研究。
Environ Health Prev Med. 2023;28:61. doi: 10.1265/ehpm.23-00099.
10
Development of a Cardiovascular Disease Risk Prediction Model Using the Suita Study, a Population-Based Prospective Cohort Study in Japan.利用日本 Suita 研究(一项基于人群的前瞻性队列研究)开发心血管疾病风险预测模型。
J Atheroscler Thromb. 2020 Nov 1;27(11):1160-1175. doi: 10.5551/jat.48843. Epub 2020 Feb 6.

引用本文的文献

1
Developing a risk score for B-type natriuretic peptide (BNP) ≥ 100 pg/ml levels: the suita study.开发用于B型利钠肽(BNP)≥100 pg/ml水平的风险评分:须田研究
BMC Cardiovasc Disord. 2025 Sep 2;25(1):649. doi: 10.1186/s12872-025-05031-w.
2
Association of Heavy Smoking With High Body Mass Index and Cardiovascular Risk Score in Japan.日本重度吸烟与高体重指数及心血管风险评分的关联。
Obes Sci Pract. 2025 Aug 16;11(4):e70089. doi: 10.1002/osp4.70089. eCollection 2025 Aug.
3
Machine learning-based high-benefit approach versus traditional high-risk approach in statin therapy: the Shizuoka Kokuho database study.

本文引用的文献

1
Development of a Cardiovascular Disease Risk Prediction Model Using the Suita Study, a Population-Based Prospective Cohort Study in Japan.利用日本 Suita 研究(一项基于人群的前瞻性队列研究)开发心血管疾病风险预测模型。
J Atheroscler Thromb. 2020 Nov 1;27(11):1160-1175. doi: 10.5551/jat.48843. Epub 2020 Feb 6.
2
Development and validation of modified risk prediction models for cardiovascular disease and its subtypes: The Hisayama Study.改良心血管疾病及其亚型风险预测模型的建立与验证:日山研究。
Atherosclerosis. 2018 Dec;279:38-44. doi: 10.1016/j.atherosclerosis.2018.10.014. Epub 2018 Oct 17.
3
Japanese Legacy Cohort Studies: The Hisayama Study.
他汀类药物治疗中基于机器学习的高获益方法与传统高风险方法的比较:静冈国保数据库研究
Sci Rep. 2025 Jul 29;15(1):27627. doi: 10.1038/s41598-025-11236-y.
4
The incidence of vascular adverse events and usefulness of novel risk assessment tool in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.日本慢性髓性白血病患者接受酪氨酸激酶抑制剂治疗时血管不良事件的发生率及新型风险评估工具的效用
Cardiooncology. 2025 Jul 19;11(1):68. doi: 10.1186/s40959-025-00366-x.
5
High levels of pericoronary adipose tissue inflammation are associated with coronary atherosclerosis independent of epicardial adipose tissue volume in patients with chronic coronary syndrome.在慢性冠状动脉综合征患者中,冠状动脉周围脂肪组织的高水平炎症与冠状动脉粥样硬化相关,且独立于心外膜脂肪组织体积。
Eur Heart J Imaging Methods Pract. 2025 Jun 10;3(2):qyaf079. doi: 10.1093/ehjimp/qyaf079. eCollection 2025 Jul.
6
Enhancing Postprandial Hyperglycemia Detection Sensitivity in Individuals With Impaired Glucose Tolerance by Incorporating 1,5-Anhydroglucitol Into Diagnostic Testing: A Multicenter and Prospective Observational Study.通过将1,5-脱水葡萄糖醇纳入诊断测试提高糖耐量受损个体餐后高血糖检测敏感性:一项多中心前瞻性观察研究
Cureus. 2025 May 1;17(5):e83297. doi: 10.7759/cureus.83297. eCollection 2025 May.
7
Atherosclerotic Cardiovascular Disease Risk Prediction Models in China, Japan, and Korea: Implications for East Asians?中国、日本和韩国的动脉粥样硬化性心血管疾病风险预测模型:对东亚人有何启示?
JACC Asia. 2025 Mar;5(3 Pt 1):333-349. doi: 10.1016/j.jacasi.2025.01.006.
8
Digital Health Interventions for Atherosclerotic Cardiovascular Disease: The Current Impact and Future Directions for Prevention and Management.用于动脉粥样硬化性心血管疾病的数字健康干预措施:当前的影响以及预防和管理的未来方向
J Atheroscler Thromb. 2025 Apr 1;32(4):395-404. doi: 10.5551/jat.RV22032. Epub 2025 Jan 31.
9
Evaluating Pericoronary Adipose Tissue Attenuation to Predict Cardiovascular Events: A Multicenter Study in East Asians.评估冠状动脉周围脂肪组织衰减以预测心血管事件:一项针对东亚人群的多中心研究。
JACC Asia. 2024 Nov 12;5(1):1-11. doi: 10.1016/j.jacasi.2024.09.009. eCollection 2025 Jan.
10
Predictors of Atherosclerotic Cardiovascular Disease Events in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病患者动脉粥样硬化性心血管疾病事件的预测因素
Intern Med. 2025 Jun 15;64(12):1791-1798. doi: 10.2169/internalmedicine.4373-24. Epub 2024 Nov 21.
日本遗族队列研究:久山研究。
J Epidemiol. 2018 Nov 5;28(11):444-451. doi: 10.2188/jea.JE20180150. Epub 2018 Oct 6.
4
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.日本动脉粥样硬化协会(JAS)2017年动脉粥样硬化性心血管疾病预防指南。
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984. doi: 10.5551/jat.GL2017. Epub 2018 Aug 22.
5
Prevalence of Systemic Atherosclerosis Burdens and Overlapping Stroke Etiologies and Their Associations With Long-term Vascular Prognosis in Stroke With Intracranial Atherosclerotic Disease.颅内动脉粥样硬化性疾病所致卒中患者的系统性动脉粥样硬化负担和重叠性卒中病因及其与长期血管预后的相关性
JAMA Neurol. 2018 Feb 1;75(2):203-211. doi: 10.1001/jamaneurol.2017.3960.
6
Self-Care for the Prevention and Management of Cardiovascular Disease and Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association.《心血管疾病和卒中的预防与管理中的自我保健:美国心脏协会医疗保健专业人员科学声明》。
J Am Heart Assoc. 2017 Aug 31;6(9):e006997. doi: 10.1161/JAHA.117.006997.
7
Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China).预测中国人群动脉粥样硬化性心血管疾病 10 年风险:中国 PAR 项目(中国 ASCVD 风险预测)。
Circulation. 2016 Nov 8;134(19):1430-1440. doi: 10.1161/CIRCULATIONAHA.116.022367. Epub 2016 Sep 28.
8
Prediction models for cardiovascular disease risk in the general population: systematic review.普通人群心血管疾病风险预测模型:系统评价
BMJ. 2016 May 16;353:i2416. doi: 10.1136/bmj.i2416.
9
Development of a Risk Equation for the Incidence of Coronary Artery Disease and Ischemic Stroke for Middle-Aged Japanese - Japan Public Health Center-Based Prospective Study.日本中年人群冠状动脉疾病和缺血性中风发病率风险方程的开发——基于日本公共卫生中心的前瞻性研究
Circ J. 2016 May 25;80(6):1386-95. doi: 10.1253/circj.CJ-16-0081. Epub 2016 Apr 15.
10
High-Risk Atherosclerotic Cardiovascular Disease in a Real-World Employed Japanese Population: Prevalence, Cardiovascular Event Rates, and Costs.日本在职人群中的高危动脉粥样硬化性心血管疾病:患病率、心血管事件发生率及成本
J Atheroscler Thromb. 2015;22(12):1287-304. doi: 10.5551/jat.28852. Epub 2015 Aug 18.